Trial intelligence / Profile preview

Celecoxib for Autism in Children

IRCT138711091556N2Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of celecoxib in Autism Spectrum Disorder (ASD), sponsored by Tehran University of Medical Sciences. Started Feb 2009; status: completed.

02

Drugs

celecoxib
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on IRCT138711091556N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138711091556N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call